Reply to Comment

Author： Lynch B.S.   Capen C.C.   Nestmann E.R.   Veenstra G.   Deyo J.A.  

Publisher： Academic Press

ISSN： 0273-2300

Source： Regulatory Toxicology and Pharmacology, Vol.32, Iss.3, 2000-12, pp. : 339-340

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Comment

By Carr C.J.  

Regulatory Toxicology and Pharmacology, Vol. 27, Iss. 3, 1998-06 ,pp. : 280-280

Academic Press

Access to resources Recommend Favorite

Comment and reply on: Vasohibin-1 and its emerging role in the evolution and progression of systemic tumors besides renal cell carcinomas

By Kapoor Shailendra  

Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 1, 2013-01 ,pp. : 105-106

Informa Healthcare

Access to resources Recommend Favorite

Comment and reply on: Pegfilgrastim is safe and effective in the prevention of neutropenia and treatment delays in biweekly regimens

By Santini Daniele   Frezza Anna Maria   Venditti Olga   Intagliata Salvatore   dell'Aquila Emanuela   Guida Francesco   Vincenzi Bruno   Tonini Giuseppe  

Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 4, 2013-04 ,pp. : 473-475

Informa Healthcare

Access to resources Recommend Favorite

Comment and reply on:Emerging role of Th22 and IL-22 in multiple sclerosis, an autoimmune disease in the central nervous system

By Zhou Chunkui   Zhang Beilin   Yang Yi   Zhang Hongliang  

Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 11, 2013-11 ,pp. : 1381-1382

Informa Healthcare

Access to resources Recommend Favorite

Reply to ESMO guidelines committee comment on ‘Critical evaluation of the scientific content in clinical practice guidelines’

By Abdelsattar Zaid M.   Wong Sandra L.  

Cancer, Vol. 121, Iss. 11, 2015-06 ,pp. : 1908-1909

Blackwell Publishing

Access to resources Recommend Favorite